Skip to main content
Saniona logo

Saniona — Investor Relations & Filings

Ticker · SANION ISIN · SE0005794617 LEI · 549300XO4L9XNOCFCZ84 ST Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2023-11-21 Regulatory Filings
Country SE Sweden
Listing ST SANION

About Saniona

http://saniona.com

Saniona is a clinical-stage biopharmaceutical company focused on the research and development of treatments for neurological disorders, with a primary emphasis on epilepsy. The company is a leader in the field of ion channel modulation, leveraging its expertise and a proprietary drug discovery engine to create new medicines. Saniona has developed an extensive library of over 20,000 proprietary molecules designed to target various ion channels. Its pipeline includes multiple potential new medicines advancing through clinical trials, with the goal of addressing unmet medical needs for patients with central nervous system diseases.

Recent filings

Filing Released Lang Actions
Saniona väljer Kv7 substans för att utse läkemedelskandidat inom epilepsi
Regulatory Filings Classification · 95% confidence The document is a press release from Saniona announcing the initiation of a candidate selection phase for a new epilepsy drug (Kv7 substance). It provides details on the research progress, the mechanism of action, and the company's pipeline. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement (RPA) as it is the primary announcement itself. As it is a general corporate regulatory announcement regarding business operations and R&D progress, it falls under the RNS (Regulatory Filings) category.
2023-11-21 Swedish
Saniona promotes Kv7 epilepsy compound to candidate selection phase
Regulatory Filings Classification · 95% confidence The document is a press release issued by Saniona regarding the advancement of a specific drug compound (Kv7) to the candidate selection phase. It does not report financial results, governance changes, or shareholder meetings, but rather provides a corporate update on research and development activities. As it is a general regulatory announcement that does not fit into more specific categories like M&A or financial reporting, it is classified as a Regulatory Filing (RNS).
2023-11-21 English
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'INTERIM REPORT FOR SANIONA AB (PUBL) January – June 2023'. It contains comprehensive financial data, including income statements for the three and six months ended June 30, 2023, business highlights, CEO commentary, and detailed pipeline status. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-31 English
Change in numbers of shares and votes in Saniona AB
Share Issue/Capital Change Classification · 100% confidence The document is a press release from Saniona AB announcing a change in the total number of shares and votes due to a new issue of shares. This type of corporate disclosure regarding changes in share capital is specifically categorized under 'Share Issue/Capital Change' (SHA).
2023-08-31 English
Ändring av antalet aktier och röster i Saniona AB
Share Issue/Capital Change Classification · 100% confidence The document is a press release from Saniona AB announcing a change in the total number of shares and votes due to a debt-for-equity swap (kvittningsemission). This type of announcement, which details changes in share capital structure, falls under the category of share issues or capital changes.
2023-08-31 Swedish
Saniona executes the set-off issue to Formue Nord
Share Issue/Capital Change Classification · 100% confidence The document is a press release announcing a 'set-off issue' of new shares to a creditor (Formue Nord) to settle debt and fees. This constitutes a change in the company's capital structure and share count. According to the provided definitions, an announcement regarding new share issues or capital changes falls under the 'Share Issue/Capital Change' (SHA) category.
2023-08-15 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.